Global Closed Loop Insulin System Market Research Report: Forecast (2025-2030)

Market Definition

Automated insulin delivery systems have a combination of a glucose monitor and an insulin pump to assist patients suffering from type 1 diabetes in managing their blood sugar levels. These are also known as hybrid closed-loop systems, and can detect changes in sugar levels in real-time and automatically adjust insulin doses in response.

Market Insights & Analysis: Global Closed Loop Insulin System Market (2025-30):

The Global Closed-loop Insulin System Market size was valued at around USD33.2 Billion in 2024 and is projected to reach USD53.33 Billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 8.3% during the forecast period, i.e., 2025-30. This market is growing at a rapid pace, driven by the increasing aging population and growing awareness of diabetes management. The world is aging, and age-related issues are rising too, including diabetes, at a highly significant rate. By 2030, 1 in every 6 individuals will be around 60 years or more of age worldwide as stated by the World Health Organization (WHO), with the total number of people aged 60 and over growing from 1 billion in 2020 to 1.4 billion by 2030.

This population change has a direct linkage with the need for an enhanced management of diabetes. Based on various research studies in the past, the incidence of diabetes has been witnessed at its maximum rate among persons between 65 and 74 years of age. As one gets older, the susceptibility towards Type 2 diabetes is more because of a lack of physical movement, slow metabolic rate, and other related complications that come along with age. Also, diabetes prevalence is much greater in urban settings (6.2%) than in rural settings, which indicates differences in lifestyle that lead to the disease. A new closed-loop system offers a solution to this issue. Closed-loop insulin systems simplify diabetes management by automatically regulating blood glucose and the necessary insulin delivery without putting burdens on old-age people who are using challenging manual glucose monitoring devices and insulin injection procedures. With growing consciousness regarding complications linked to diabetes and the advantages of closed-loop insulin systems, in combination with the expansion of the geriatric population, the use of closed-loop insulin systems is rising around the world to maintain better quality and management for diabetics.

Boost strategic growth with in-depth market analysis - Get a free sample preview today!

Global Closed Loop Insulin System Market Driver:

Increasing prevalence of diabetes – There has been an increasing incidence of diabetes in the world fueled by changing lifestyles and poor dietary habits. As per the World Health Organization, the number of cases of diabetes has risen from 200 million in 1990 to 830 million in 2022, increasing day by day, especially in developing nations like North America and the Middle East.  Diabetes caused 1.6 million deaths in 2021, of which 47% of deaths were attributed to patients less than 70 years old, according to the WHO. Diabetes further causes other diseases in the body, such as kidney malfunctioning, causing a mortality rate of around 530,000 globally. WHO estimates that diabetes will double and reach over 1.3 billion cases by 2050. There are roughly 9 million patients having Type 1 diabetes in the world who require insulin for survival, along with roughly 60 million patients with Type 2, who require insulin treatment to maintain their glycemic status under control. So these products offer enhanced solutions for diabetes management options to mitigate the suffering of this condition around the world.

Global Closed Loop Insulin System Market Challenge:

High Cost of Insulin System – Fundamental challenges related to closed-loop insulin systems include their high costs, especially for lower and middle-income countries. These systems are highly priced and therefore inaccessible in these areas compared to the developed, high-income international countries. Even in prosperous countries, the value stays a barrier for the majority of the population. The costliness of insulin adds to the cost. The price of smartphone-connected insulin pumps ranges from USD4,500-USD6,500 and the sensor-based continuous glucose monitor’s price is in the range of USD1,000-USD1,400. This high initial cost, coupled with the cost for associated consumables, has resulted in low accessibility of smart insulin systems and is a barrier to the growth of the market.

Global Closed Loop Insulin System Market Trend:

Integration of AI & ML for More Precise Glucose Management – The blend of artificial intelligence (AI) and machine learning (ML) is a developing trend in the Closed-Loop Insulin machine marketplace, helping to improve the precision and performance of glucose management. These superior technologies allow the machine to investigate large quantities of real-time information from continuous glucose video display units (CGMs) and insulin pumps. AI-powered algorithms examine patterns in an affected person’s blood sugar levels and predict changes based on elements like meals, activity levels, and sleep. This predictive capability ensures greater correct insulin transport, lowering the danger of excessive or low blood sugar levels. Machine-gaining knowledge also helps customize diabetes management by way of adapting the machine to a man or woman's wishes over the years, enhancing treatment results. By incorporating AI and ML, closed-loop systems have become smarter, more reliable, and better at supporting sufferers in handling diabetes efficaciously. This trend is remodeling diabetes care, making these systems a favored choice for superior and automated glucose management solutions.

Global Closed Loop Insulin System Market (2025-30): Segmentation Analysis

The Global Closed Loop Insulin System Market study of MarkNtel Advisors evaluates & highlights the major trends & influencing factors in each segment. It includes predictions for the period 2025-2030 at the global level. Based on the analysis, the market has been further classified as:

Based on Product:

• Threshold Suspended
• CTR System Control-to-Range System
• CTT System Control-to-Target System

Based on the product, the threshold suspended segment has the largest market share around 45%, because it applies to a wide range of industries and has a specific demand. The system is advanced in technology, reliability, and adaptability in manufacturing and automation. They work on predefined thresholds, thus providing efficient solutions for monitoring and control, reducing operational risks, and ensuring compliance with stringent regulations. Their scalability and integration capabilities further enhance their appeal, driving widespread adoption.

Based on End-User:

• Home Care
• Hospital & Clinics
• Nursing Home

Based on end-user, the hospitals and clinics segment has the largest market share of around 50% in the closed-loop insulin systems market. Hospitals and clinics are primary centers for diabetes management, offering advanced care and technologies for patients requiring continuous glucose monitoring and insulin delivery. These facilities often cater to a higher volume of patients with severe or uncontrolled diabetes, driving the demand for closed-loop systems due to their precision, reliability, and ability to improve patient outcomes. Moreover, healthcare professionals in hospitals and clinics are well-trained in using and recommending such systems, further, hospitals remain dominant, as they are the first point of diagnosis, treatment initiation, and monitoring for patients requiring advanced insulin management solutions.

Global Closed Loop Insulin System Market (2025-30): Regional Projections

Geographically, the Global Closed Loop Insulin System Market expands across:

• North America
• South America
• Europe
• The Middle East & Africa
• Asia-Pacific

North America's Closed-Loop Insulin System Market is anticipated to witness significant growth in the forecast period of around 45%. The rising healthcare expenditure, strong healthcare infrastructure, and growing awareness among the population for advanced diabetes management solutions are augmenting the volume of the North American Closed-Loop Insulin System Market. Furthermore, the high incidence of type 2 diabetes and the growing need for better glycemic management contribute to the use of this system. For instance, as per the American Diabetes Association in 2021, around 38.4 million Americans, or around 11 of the population, have diabetes. 2 million Americans have type 1 diabetes, including about 304,000 children and adolescents and around 38.4 million adults with diabetes, 29.7 million were diagnosed, and 8.7 million were undiagnosed. Thus, with the increasing prevalence of diabetes and the rise of the geriatric population increasing the demand for the closed-loop insulin system market.

Gain a Competitive Edge with Our Global Closed Loop Insulin System Market Report

1. Global Closed Loop Insulin System Market Report by MarkNtel Advisors provides a detailed & thorough analysis of market size & share, growth rate, competitive landscape, and key players. This comprehensive analysis helps businesses gain a holistic understanding of the market dynamics & make informed decisions.
2. This report also highlights current market trends & future projections, allowing businesses to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition.
3. Global Closed Loop Insulin System Market Report aids in assessing & mitigating risks associated with entering or operating in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, businesses can develop strategies to minimize risks & optimize their operations.

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.